Hussain M, Goyal A, Goyal K, S R, Nellore J, Shahwan M
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40047857
DOI: 10.1007/s00210-025-03970-x.
Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q
Mol Cancer. 2025; 24(1):51.
PMID: 39994787
PMC: 11849313.
DOI: 10.1186/s12943-025-02243-8.
Kawashima J, Endo Y, Rashid Z, Altaf A, Woldesenbet S, Tsilimigras D
Hepatobiliary Surg Nutr. 2025; 14(1):3-15.
PMID: 39925922
PMC: 11806131.
DOI: 10.21037/hbsn-24-385.
Seres M, Spacayova K, Sulova Z, Spaldova J, Breier A, Pavlikova L
Cancers (Basel). 2025; 17(2).
PMID: 39858030
PMC: 11763799.
DOI: 10.3390/cancers17020248.
Wang Y, Bui T, Yang X, Hutvagner G, Deng W
Cancer Metastasis Rev. 2025; 44(1):24.
PMID: 39820726
PMC: 11748474.
DOI: 10.1007/s10555-025-10243-9.
Oncogenic RAS in Cancers from the DNA Replication Stress and Senescence Perspective.
Techer H, Kemiha S, Aobuli X, Kolinjivadi A
Cancers (Basel). 2024; 16(23).
PMID: 39682179
PMC: 11640673.
DOI: 10.3390/cancers16233993.
Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review).
Zhang J, Feng Y, Li D, Shi D
Oncol Lett. 2024; 29(1):50.
PMID: 39564373
PMC: 11574707.
DOI: 10.3892/ol.2024.14796.
A key regulator of tumor-associated neutrophils: the CXCR2 chemokine receptor.
Kang W, Wang C, Wang M, Liu M, Hu W, Liang X
J Mol Histol. 2024; 55(6):1051-1061.
PMID: 39269537
DOI: 10.1007/s10735-024-10260-y.
Decoding potential targets and pharmacologic mechanisms of curcumin in treating non-small cell lung carcinoma via bioinformatics and molecular docking.
Li J, Zhang Z, Zhao J, Liu S, Feng C, Deng H
Braz J Med Biol Res. 2024; 57:e13550.
PMID: 39258670
PMC: 11379430.
DOI: 10.1590/1414-431X2024e13550.
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors.
He D, Bai R, Chen N, Cui J
Chin J Cancer Res. 2024; 36(4):421-441.
PMID: 39246706
PMC: 11377883.
DOI: 10.21147/j.issn.1000-9604.2024.04.06.
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer.
Casacuberta-Serra S, Gonzalez-Larreategui I, Capitan-Leo D, Soucek L
Signal Transduct Target Ther. 2024; 9(1):205.
PMID: 39164274
PMC: 11336233.
DOI: 10.1038/s41392-024-01907-z.
Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines.
Huber A, Allam A, Dijkstra C, Thiem S, Huynh J, Poh A
Cell Rep. 2024; 43(8):114616.
PMID: 39128004
PMC: 11372443.
DOI: 10.1016/j.celrep.2024.114616.
Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy.
Gauthier M, Pierson J, Moulin D, Mouginot M, Bourguignon V, Rhalloussi W
Immunotargets Ther. 2024; 13:319-333.
PMID: 38948503
PMC: 11214763.
DOI: 10.2147/ITT.S458278.
Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment.
Kubo T, Nishimura N, Kaji K, Tomooka F, Shibamoto A, Iwai S
Int J Mol Sci. 2024; 25(8).
PMID: 38673992
PMC: 11050651.
DOI: 10.3390/ijms25084405.
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.
Enfield K, Colliver E, Lee C, Magness A, Moore D, Sivakumar M
Cancer Discov. 2024; 14(6):1018-1047.
PMID: 38581685
PMC: 11145179.
DOI: 10.1158/2159-8290.CD-23-1380.
Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies.
Linehan A, OReilly M, McDermott R, OKane G
Front Med (Lausanne). 2024; 11:1369136.
PMID: 38576709
PMC: 10991798.
DOI: 10.3389/fmed.2024.1369136.
Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review.
Bastias D, Maturana A, Marin C, Martinez R, Niklander S
Int J Mol Sci. 2024; 25(5).
PMID: 38473882
PMC: 10932009.
DOI: 10.3390/ijms25052634.
Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy.
Meo C, de Nigris F
Cancers (Basel). 2024; 16(3).
PMID: 38339244
PMC: 10854702.
DOI: 10.3390/cancers16030491.
Brain injury drives optic glioma formation through neuron-glia signaling.
Chatterjee J, Koleske J, Chao A, Sauerbeck A, Chen J, Qi X
Acta Neuropathol Commun. 2024; 12(1):21.
PMID: 38308315
PMC: 10837936.
DOI: 10.1186/s40478-024-01735-w.
Immunosurveillance encounters cancer metabolism.
Chuang Y, Tzeng S, Ho P, Tsai C
EMBO Rep. 2024; 25(2):471-488.
PMID: 38216787
PMC: 10897436.
DOI: 10.1038/s44319-023-00038-w.